FDA Import Refusal 799-5453625-8/10003/1 — Abbvie Corporation
The FDA refused shipment 799-5453625-8/10003/1 from Abbvie Corporation (Canada) on Oct 22, 2025. The refused product falls under Drugs and Biologics — RISANKIZUMAB-RZAA. Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Oct 22, 2025
- Country
- Canada
- Product Category
- Drugs and Biologics
- Product Code
- 58MCY09 RISANKIZUMAB-RZAA
- Charges
- 75